Hemato Oncology Testing Market Forecast By 2020-2027 Global Demand, Supply, SWOT Analysis With Key Players like Abbott Laboratories, EntroGen, Inc., Qiagen N.V., Cepheid

Hemato Oncology Testing Market Forecast By 2020-2027 Global Demand, Supply, SWOT Analysis With Key Players like Abbott Laboratories, EntroGen, Inc., Qiagen N.V., Cepheid

Grand View Research, Inc. – Market Research And Consulting.
Hemato Oncology Testing Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Services), By Cancer Type (Leukemia, Lymphoma, MPNs), By Technology, By End-use, By Region, And Segment Forecasts, 2020 – 2027

The global hemato oncology testing market size is expected to reach USD 7.2 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.6% from 2020 to 2027. Key drivers for the market include rising incidences of leukemia, lymphoma, myeloproliferative neoplasms, and multiple myeloma. Also, growing collaborations among various major players and research organizations, and an increasing number of research activities conducted by academic and research institutes to develop technologically advanced hemato oncology tests is anticipated to fuel market growth.

The rising prevalence of lymphoma and myeloma is anticipated to propel the market growth during the forecast period. According to a report published by the American Cancer Society, it is estimated that there over 32,270 new cases of multiple myeloma which included 14,740 women and 17,530 men in 2018. Whereas, over 12,830 deaths were recorded in 2018 that included 5,640 women and 7,190 men. Therefore, a rise in the prevalence of the above-mentioned diseases is expected to enhance the usage of hemato oncology testing products.

An increase in the number of product launches is also a major factor contributing to the growth of the market. For instance, in October 2018, MedGenome launched the IGHV gene mutation testing. This test enables health care professionals to access the prognosis of chronic lymphocytic leukemia, and further manage the disease by personalized therapy.

The FDA approval of Invivoscribe’s LeukoStrat companion diagnostic test in conjugation with Novartis’s Rydapt for detection and treatment of AML has been a key factor in the rising number of manufacturers opting for the development of related products. The CE approved assay was launched in 2017, being the first companion diagnostic to be used for the detection of AML. Similarly, in the year 2018, Invivoscribe announced the U.S. FDA’s approval for LeukoStrat CDx FLT3 Mutation Assay and XOSPATA, an AML drug manufactured by Astellas Pharma.

Request a free sample copy @ https://www.grandviewresearch.com/industry-analysis/hemato-oncology-testing-market/request/rs1

Growing collaborations among market players and academic and research organizations are anticipated to boost growth during the forecast period. For instance, in May 2018, Invivoscribe Technologies Inc. collaborated with the American University of Beirut Medical Center (AUBMC) in order to design and build a new center for excellence treatment in the Middle East region for advanced research in hemato oncology testing as well as treatment.

U.S. hemato oncology testing market size, by end-use, 2016 - 2027 (USD Million)

Hemato Oncology Testing Market Report Highlights

  • Lymphoma held a dominant share in terms of revenue in the cancer type segment owing to a rise in the prevalence of Hodgkin and Non-Hodgkin Lymphoma
  • The services segment captured the largest market share due to an increase in the incidence rate and rising awareness regarding various treatment therapies such as personalized medicines
  • The PCR segment dominated the market in terms of revenue share in 2019 and witnessed exponential growth owing to its ease in use, affordability, the accuracy and efficiency provided, rise in the number of product launches and approval, technological advancements of testing products, and easy availability
  • The hospitals segment witnessed exponential growth in 2019 owing to the availability of hemato oncology diagnostic tests and the presence of healthcare professionals to conduct diagnostic tests and monitor the disease
  • In North America, the market is expected to witness exponential growth during the forecast period owing to a rise in the prevalence of multiple myeloma, the growing number of awareness and screening campaigns, and the launch of technologically advanced products for the diagnosis of hemato oncology

Ask To Our Experts For Special Pricing @ https://www.grandviewresearch.com/special-pricing/451031/rfsp1

North America hemato oncology testing market share, by cancer type, 2019 (%)

Chapter 1 Methodology and Scope
                   1.1 Market segmentation & scope
                   1.2 Market definition
                   1.3 Information procurement
                       1.3.1 Purchased Database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources & Third Party Perspectives
                       1.3.4 Primary Research
                   1.4 Information analysis
                       1.4.1 Data Analysis Models
                   1.5 Market formulation & data visualization
                   1.6 Data validation & publishing
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Outlook
                   2.3 Competitive Insights
Chapter 3 Hemato Oncology Testing Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                       3.1.2 Ancillary market outlook
                   3.2 Penetration and Growth Prospect Mapping
                       3.2.1 User perspective analysis
                  Consumer behavior analysis
                   3.3 Regulatory Framework
                       3.3.1 Reimbursement framework
                       3.3.2 Standards and compliances
                   3.4 Market Dynamics
                       3.4.1 Market driver analysis
                  Increasing prevalence of lymphoma & myeloma
                  Growing demand for personalized therapy
                  Availability of advanced molecular techniques for hemato-oncology diagnostics
                  Increasing drug-diagnostics co-development
                       3.4.2 Market restraint analysis
                  Unfavorable reimbursement scenario
                       3.4.3 Market opportunities analysis
                  Developing countries provide untapped markets for multinational players
                       3.4.4 Market challenges analysis
                  Intellectual property rights protection issues
                   3.5 Hemato Oncology Testing Market Analysis Tools
                       3.5.1 INDUSTRY ANALYSIS – PORTER’S
                  Supplier Power
                  Buyer Power
                  Substitution Threat
                  Threat from new entrants
                  Competitive Rivalry
                       3.5.2 PESTEL ANALYSIS
                  Political Landscape
                  Environmental Landscape
                  Social landscape
                  Services landscape
                  Legal Landscape


Read Related Report

Blood Testing Market Size, Share & Trends Analysis Report By Test Type (Glucose, Lipid, BUN, A1C, Vitamin D, ALT, AST, Thyroid Stimulating Hormone, PSA), By Region, And Segment Forecasts, 2020 – 2027


Polymerase Chain Reaction Market Size, Share & Trends Analysis Report By Type, By Product (Instruments, Consumables & Reagents, Software & Services), By Application, By Region, And Segment Forecasts, 2020 – 2027


About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/hemato-oncology-testing-market